1 |
Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45:1366-74.
DOI
|
2 |
Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology. 2004;40:185-94.
DOI
|
3 |
Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28:370-9.
DOI
|
4 |
Kim TH. Obesity and fatty liver disease. Korean Journal of Medcine. 2005;68(4):347-50.
|
5 |
Baeuerle PA, Baltimore D. - Ten years after. Cell 1996;87:13-20.
DOI
|
6 |
Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 2003;17(14):2115-7.
DOI
|
7 |
Cha HY, Ahn SH, Cheon JH, Park IS, Kim JT, Kim KB. Hataedock treatment has preventive therapeutic effects in atopic dermatitis-induced NC/Nga mice under high-fat diet conditions. Evid Based Complement Alternat Med. 2016:1-13.
|
8 |
Lipscombe LL, Gomes T, Levesque LE, Hux JE, Juurlink DN, Alter DA. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA 2007;298:2634-43.
DOI
|
9 |
Lili G, Haiyan F, Dezheng G, Xu Z, Li C, Qiong W, Bo Y, Mei Y, Jie Z, Yuan Z. Genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction. Experimental Gerontology. 2013;48(12):1387-94.
DOI
|
10 |
Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 2007;298:1180-8.
DOI
|
11 |
Ahn YJ, Yoon KH, Jo JH, Jang DH, Jung YS, Kim JH, Kim BC, Seok HJ, Yoo JS, Ku JR, Yoon M, Shin SS. Gangjihwan Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed C57BL/6N Mice. Kor. J. Herbology 2014;29(2):47-54.
DOI
|
12 |
Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006;40 Suppl 1:S5-10.
|
13 |
Korea Food & Drug Administration. The press release. Retrieved Nov. 14, 2013. Available from http://www.mfds.go.kr/index.do?mid=675&seq=19618&cmd=v
|
14 |
Oh K, Jang MJ, Lee NY, Moon JS, Lee CG, Yoo MH. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Korean J Pediatr. 2008;51:950-5.
DOI
|
15 |
Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28:155-61.
DOI
|
16 |
Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE. Review article epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008;28:13-24.
DOI
|
17 |
Lee BW. Management of Patients with Nonalcoholic Fatty Liver Disease with Lifestyle Modification. Korean Diabetes. 2018;19:82-7.
DOI
|
18 |
Xu J, Lee WN, Phan J, Saad MF, Reue K, Kurland IJ. Lipin deficiency impairs diurnal metabolic fuel switching. Diabetes. 2006;55(12):3429-38.
DOI
|
19 |
Cone CJ, Bachyrycz AM, Murata GH. Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. Ann Pharmacother. 2010;44(10):1655-9.
DOI
|
20 |
Peterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet. 2001; 27:121-4.
DOI
|
21 |
Kim K, Ko H, Shin S. Diagnostic Process Analysis of Prescribing Injinho-tang in Non Alcohoic Fatty Liver Disease Using by AHP. The Journal of the Society of Korean Medicine Diagnostics. 2015;19(3):159-71.
|
22 |
Yao-Borengasser A, Rasouli N, Varma V, Miles LM, Phanavanh B, Starks TN, Phan J, Spencer HJ 3rd, McGehee RE Jr, Reue K, Kern PA. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes. 2006;55(10):2811-8.
DOI
|
23 |
Jeong HS, Lee YS, Won JH, Hwang JT. Baek DG. Effect of The Gardenia jsaminodes and Glycine max and Chijasi-tang Extract on Acute Liver Damage Induced by Galactosamine in Rats. The Journal of Internal Korean Medicine. 2013:34(3);303-14.
|
24 |
Ko H, Kim KT, Shin SM. Study on Validity of Using Injinho-tang in Non Alcohoic Fatty Liver Disease. Korean J. Oriental Physiology & Pathology. 2012;26(6):823-33.
|
25 |
Jang YS, Seo JY, kwun MJ, Kwon JN, Lee I, Hong JW, Kim SY, Choi JY, Park SH, Joo M, Han CW. Effect of Phaseolus angularis Seed on Experimental Cellular Model of Nonalcoholic Fatty Liver Disease. Korean J. Oriental Physiology & Pathology. 2013;27(6):802-8.
|
26 |
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-95.
DOI
|
27 |
Kim SY, Kwon JN, Lee I, Hong JW, Choi JY, Park SH, Kwon MJ, Joo M, Han CW. Research on Anti-lipogenic Effect and Underlying Mechanism of Laminaria japonica on Experimental Cellular Model of Non-alcoholic Fatty Liver Disease. J. Int. Korean Med. 2014;35(2):175-83.
|
28 |
Jung YS, Kim JH, Kim BC, Seok HJ, Yoo JS, Ku JR, Yoon KH, Jo JH, Jang DH, Yun HY, Yoon M, Shin SS. Comparison of Gangjihwan-1,2,3,4 and Combination of Gangjihwan-1 and Gamisochehwan in the Improvement Effects of Nonalcoholic Fatty Liver Disease in a High Fat Diet-Fed Obese Mouse Model. Kor. J. Herbology. 2014;29(6):149-56.
DOI
|
29 |
Han CW, Lee JH. Effects of KHchunggan-tang on the Nonalcoholic Fatty Liver Disease in Palmitate-induced Cellular Model. J Korean Oriental Med. 2011;32(1):109-20.
|
30 |
Akbar DH, Kawther AH. Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. Diabetes Care. 2003;26:3351-2.
DOI
|
31 |
Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;129:375-8.
DOI
|
32 |
Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865-73.
DOI
|
33 |
Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology. 2004;40:820-6.
DOI
|
34 |
Park MJ, Kim DI, Lim SK, Choi JH, Kim JC, Yoon KC, Lee JB, Lee JH, Han HJ, Choi IP, Kim HC, Park SH. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1a regulation in vitro and in vivo. Journal of Hepatology. 2014;61:1151-7.
DOI
|
35 |
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113-24.
DOI
|
36 |
Son CK. The research of immunological function in liver. J Korean Oriental Med. 2001;22(1):3-9.
|